Evommune Inc. Company Profile
NYSE: EVMNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
6.22-0.39 (-5.90%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 6.22 0.00%
Evommune at a glance
Evommune Inc. (NYSE: EVMN) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector. The company's shares have traded publicly since 2025. At a market capitalization of $239.9 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0002044725, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
Company information
- Legal name
- Evommune Inc.
- Ticker
- NYSE: EVMN
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Headquarters
- United States
- IPO year
- 2025
- Market cap
- $239.89M
- SEC CIK
- 0002044725
Companies similar to Evommune
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| VOGXVogenx Inc | 16.16 | -1.40% | $240.06M | vs EVMN |
| PYXSPyxis Oncology Inc. | 2.01 | -0.49% | $240.11M | vs EVMN |
| CAMPCAMP4 Therapeutics Corporation | 3.84 | -3.03% | $240.97M | vs EVMN |
| QTTBQ32 Bio Inc. | 7.99 | -1.48% | $237.86M | vs EVMN |
| AKBAAkebia Therapeutics Inc. | 0.8734 | -0.58% | $242.02M | vs EVMN |
| VCREVicore Pharma Holding AB ADR | 8.66 | -2.74% | $243.90M | vs EVMN |
| LFCRLifecore Biomedical Inc. | 6.44 | -0.15% | $244.11M | vs EVMN |
| SLGLSol-Gel Technologies Ltd. | 71.95 | -4.88% | $235.55M | vs EVMN |